Related Experiment Videos
[Colchicine: rationale for its use in liver disease]
D Kershenobich1, J Borovoy, R L Guevara
1Departamento de Gastroenterología, Instituto Nacional de la Nutrición "Salvador Zubirán", Tlalphan, 14000 México, DF.
Summary
Colchicine, derived from the Colchicum Autumnale plant, effectively treats gout and various liver conditions. Studies show it significantly reduces mortality rates in cirrhotics and lowers interleukin-1 levels in primary biliary cirrhosis patients.
Area of Science:
- Pharmacology
- Hepatology
- Immunology
Context:
- Colchicine, a natural compound from Colchicum Autumnale, has established pharmacological applications.
- Its use has expanded beyond acute gout to include various liver diseases like cirrhosis.
- Previous research indicates colchicine's potential benefits in managing inflammatory conditions.
Purpose:
- To summarize the diverse pharmacological uses of colchicine.
- To highlight colchicine's efficacy in treating liver cirrhosis.
- To present evidence on colchicine's impact on mortality and inflammatory markers in liver disease.
Summary:
- Colchicine, initially for gout, is now used for Mediterranean familial fever and liver cirrhosis (alcoholic, posthepatitic, primary biliary).
- Clinical studies demonstrate colchicine significantly reduces mortality rates in patients with liver cirrhosis.
- Furthermore, colchicine has been shown to decrease interleukin-1 levels in primary biliary cirrhosis patients.
Impact:
- Colchicine offers a viable therapeutic option for managing liver cirrhosis, potentially improving patient survival.
- The anti-inflammatory properties of colchicine, evidenced by reduced interleukin-1, suggest broader applications in inflammatory diseases.
- This research underscores the importance of natural compounds in modern medicine for complex diseases.
Related Concept Videos
01:10Drugs that Destabilize Microtubules
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:17Chronic Bowel Disorders: Introduction
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...